Health Idea Now
Thursday, 22 November 2018
Novartis gets European approval for sight therapy Luxturna
Novartis on Friday said it had received European Union approval for its Luxturna gene therapy to restore sight to people with a rare retinal disease.
from Reuters: Health News https://ift.tt/2QccF5g
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment